CSP
2 min read
28

Nomination Committee for the AGM 2025

November 28, 2024
0

Reading Time: 2 minutes The Nomination Committee in Scandinavian Enviro Systems AB (publ) has been formed in accordance with the principles adopted by the Annual General Meeting. In accordance with the decision at Enviro’s Annual General Meeting in 2024, the company’s nomination committee for the

Continue Reading
CSP
1 min read
8

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

November 28, 2024
0

Reading Time: < 1 minute ANNOUNCEMENT NO. 258 – 28 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements

Continue Reading
Paisabazaar Introduces Advanced Fraud Detection and Prevention System Using Cutting-Edge Technologies
NV
4 min read
41

Paisabazaar Introduces Advanced Fraud Detection and Prevention System Using Cutting-Edge Technologies

November 28, 2024
0

Reading Time: 3 minutes Engine built on a combination of advanced data analytics, real-time monitoring, and machine learning techniques Internal risk scoring done for each consumer; medium risk ones monitored closely, high-risk consumers restricted from accessing offers The anti-fraud

Continue Reading
Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024
CSP
3 min read
10

Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024

November 28, 2024
0

Reading Time: 3 minutes Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will present breakthrough IND-enabling preclinical data on its drug candidate 177Lu-AKIR001 and the design of its first-in-human clinical trial at the Targeted Radiopharmaceuticals Summit Europe 2024 in Amsterdam, December 3-5. The data

Continue Reading
CSP
7 min read
7

Jetpak Top Holding AB (publ):Interim report 1 January – 30 September 2024

November 28, 2024
0

Reading Time: 5 minutes Third quarter: 1 July – 30 September June 2024  Net revenue increased by 11,7 % to 308 858 (276 583) TSEK Organic growth amounted to 1,7 % (-13,5 %) Gross margin amounted to 28,8 % (29,4 %) Adjusted EBITA amounted to

Continue Reading
PUMA Signs Blockbuster Long-Term Partnership With the Portuguese Football Federation
BWI
3 min read
27

PUMA Signs Blockbuster Long-Term Partnership With the Portuguese Football Federation

November 28, 2024
0

Reading Time: 3 minutes Herzogenaurach, Germany:   Sports company PUMA has signed a long-term agreement with the Portuguese Football Federation (FPF), one of the world’s most popular national teams. Starting in 2025, PUMA will equip all male, female and youth teams as well as the federation’s

Continue Reading
Why Homeowners Are Choosing Improving Over Moving
CSP
5 min read
12

Why Homeowners Are Choosing Improving Over Moving

November 28, 2024
0

Reading Time: 4 minutes   The traditional dream of moving to achieve your dream home goals has lost its lustre in recent years. Instead, many homeowners are now opting to invest in their existing properties in an effort to transform their current spaces into their

Continue Reading
CSP
2 min read
12

Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (26.11.2024)

November 28, 2024
0

Reading Time: 2 minutes Kesko Corporation has on 27 November 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 26 November 2024, BlackRock, Inc.’s holding in Kesko Corporation exceeded the

Continue Reading
CSP
6 min read
14

Leqembi[®] launched in South Korea

November 27, 2024
0

Reading Time: 4 minutes Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult

Continue Reading
CSP
1 min read
15

#24-407 Listing of Derivatives at NGM

November 27, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading